by clicking the arrows at the side of the page, or by using the toolbar.
by clicking anywhere on the page.
by dragging the page around when zoomed in.
by clicking anywhere on the page when zoomed in.
web sites or send emails by clicking on hyperlinks.
Email this page to a friend
Search this issue
Index - jump to page or section
Archive - view past issues
Australian Journal of Pharmacy : May 2008
You don’t need X-Ray vision to see the difference Adronat will make to your business. Alphapharm is delighted to introduce Adronat (Alendronate sodium), the latest addition to Australia’s largest range of generic medicines. Adronat makes substitution easier for pharmacy. It’s made from the same alendronate sodium trihydrate, is the same shape and the same blister packaging as the originator. In fact the only difference you, your patients and your wallet will notice is the price. So call your Alphapharm Business Advisor today to place an order. Alphapharm Pty Ltd ABN 93 002 359 739 Chase Building 2, Wentworth Park Road, Glebe NSW 2037 www.alphapharm.com.au PBS Listing 1st April 2008. Authority required (Streamlined). Treatment of osteoporosis. Refer to PBS Schedule for full authority information. Please review full product information before recommending. Full product information is available from MERCK SHARP & DOHME (AUSTRALIA) PTY LTD. Adronat (Alendronate sodium). Indication: Treatment of confirmed osteoporosis, including glucocorticoid-induced osteoporosis; Paget’s disease; Prevention of osteoporosis in postmenopausal women with low bone mass. Contraindications: Abnormalities of the oesophagus, which delay oesophageal emptying; inability to stand or sit upright for at least 30 minutes; hypersensitivity; hypocalcaemia. Precautions: Active upper GI disorders (incl. Ulceration & perforation); renal impairment; nutritional status (esp. calcium, vitD); osteonecrosis of the jaw (rare); pregnancy; lactation, children. Adverse Reactions: GI upset, dysphagia, oesophagitis, oesophageal erosions/stricture/perforation, ulceration; oropharyngeal ulceration; muscoskeletal pain; headache; myalgia; malaise; rash; pruritus, others see Full PI. Interactions: Calcium supplements, antacids, other oral meds (taken simultaneously); concomitant use of HRT (oestrogen +/- progestin); other bisphosphonates; aspirin (with daily alendronate). Dosage and Administration: Take at least 30 minutes before the first food, beverage or medication of the day with plain water only; remain upright greater than or equal to 30 minutes and until after first food; take only upon rising. Osteoporosis (men and postmenopausal women). Treatment: 70mg once weekly; prevention (postmenopausal women): 5mg once daily. Osteoporosis (due to steroids). Treatment and Prevention: 5mg daily, 10mg daily in postmenopausal women not on oestrogen. Paget’s disease: 40mg daily for up to 6 months. Merck Sharp & Dohme (Australia) PTY LTD, 54-68 Ferndell Street, South Granville, NSW 2142. Trademark of Merck & Co., Inc., Whitehouse Station, N.J., U.S.A. ALP0205.